Datar Cancer Genetics Unveils Advanced Blood Test for MRD
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Sequencing Systems |
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Womens Health |
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MorePosted by Andy Lundin | Jan 27, 2025 | Unknown Origin & Other Cancer Types |
Researchers diagnosed leptomeningeal disease in diffuse midline gliomas by detecting H3K27M-mutant ctDNA from cerebrospinal fluid.
Read MorePosted by Andy Lundin | Jan 24, 2025 | Sequencing Systems |
Researchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read MorePosted by Andy Lundin | Jan 23, 2025 | Leukemia, Sequencing Systems |
OGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read More